Phase 2 Plaque Psoriasis Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
Oruka Therapeutics, Inc.160 enrolled27 locationsNCT07474792
Recruiting
Phase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Plaque Psoriasis
Oruka Therapeutics, Inc.80 enrolled17 locationsNCT07449702
Recruiting
Phase 2
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
Oruka Therapeutics, Inc.160 enrolled26 locationsNCT07290569
Recruiting
Phase 2
Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd.172 enrolled1 locationNCT07251998
Recruiting
Phase 1Phase 2
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Chipscreen Biosciences, Ltd.220 enrolled11 locationsNCT07129382
Recruiting
Phase 2
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis
Plaque Psoriasis
Zai Lab (Hong Kong), Ltd.250 enrolled10 locationsNCT06380907
Recruiting
Phase 2
Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
Plaque Psoriasis
Tasly Pharmaceutical Group Co., Ltd180 enrolled12 locationsNCT06058546
Completed
Phase 2
Integrative medicine for plaque psoriasis combining Chinese herbal medicine with conventional therapy.
Plaque psoriasis (psoriasis vulgaris)
RMIT University30 enrolled1 locationACTRN12614000493640